storiet v.2
sign in
Capa de Early indicators, early treatments, neuroprotection in multiple sclerosis

a novel ·

Early indicators, early treatments, neuroprotection in multiple sclerosis

por

Early diagnosis is a new challenge for the neurologist, as demonstrated by the advantages of early treatment of multiple sclerosis with interferon beta. The rationale for early treatment is extensively reviewed together with the mechanism underlying irreversible damage in MS.

start reading + shelf
  • ● 85% match for you
  • ● science & technology

the long version

Early diagnosis is a new challenge for the neurologist, as demonstrated by the advantages of early treatment of multiple sclerosis with interferon beta. The rationale for early treatment is extensively reviewed together with the mechanism underlying irreversible damage in MS.

M

Margaret's verdict

"Early diagnosis is a new challenge for the neurologist, as demonstrated by the advantages of early treatment of multiple sclerosis with interferon beta. The rationale for early treatment is extensively …"

— Margaret

highlights

what readers held onto

No highlights yet. Be the first.

discussion

what readers said

No reviews yet. Finish it; tell us what you found.